MODERNA (4MRNA)
MTA
Closed
Aug 26, 2026
Day's Range
133.0052 wk Range
19.38Overview - 4MRNA - MODERNA
Key Statistics
Valuation
Enterprise Value
17.63B
Price / Book
‪3.33‬
EV / EBITDA
‪-9.42‬
Profitability
Profit Margin
‪-38.00%‬
Operating Margin
‪-109.88%‬
Return on Assets
‪-7.32%‬
Return on Equity
‪-22.04%‬
Ownership
Float
344.14M
Held by Insiders
‪9.68%‬
Held by Institutions
‪69.48%‬
Price stats
Beta
‪1.69‬
50-Day Avg
‪95.99‬
200-Day Avg
‪123.15‬
Peers - 4MRNA - MODERNA
Peer Comparison
Compared with other Stocks.
- 4MRNAMTAMODERNA+83.44%52-week change—P/E (Trailing)‪-38.00%‬Profit Margin
- 1MUMTAMicron Technology Inc.+87.38%52-week change21.80P/E (Trailing)‪55.90%‬Profit Margin
- 1WDCMTAWestern Digital Corporation+82.86%52-week change17.43P/E (Trailing)‪72.94%‬Profit Margin
- 1AMCRMTAAmcor plc+82.55%52-week change20.00P/E (Trailing)‪4.70%‬Profit Margin
- 1TWSTMTATwist Bioscience Corporation+82.28%52-week change-102.69P/E (Trailing)‪-31.66%‬Profit Margin
- 4LITEMTALUMENTUM HOLDINGS+84.67%52-week change—P/E (Trailing)‪-36.97%‬Profit Margin
- 4STXMTASEAGATE TECHNOLOGY HOLDINGS+80.22%52-week change—P/E (Trailing)‪14.67%‬Profit Margin
Profile Summary - 4MRNA - MODERNA
About
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
